Safety and antiviral activity of pradefovir in patients with chronic hepatitis B virus infection:: 48-week analysis of a phase 2 study

被引：0
|
作者：
Lim, S. G.
Lee, K. S.
Chuang, W. L.
Hwang, S. G.
Cho, M.
Lai, M. Y.
Chao, Y. C.
Chang, T. T.
Han, K. H.
Lee, C. M.
Um, S. H.
Yeon, J. E.
Yang, S. S.
Teo, E. K.
Peng, C. Y.
Lin, H. H.
Yang, S. S.
Huo, T. I.
Nguyen, T.
Chen, T. Y.
Hu, K. Q.
Xu, Y.
Sullivan-Bolyai, J. Z.
机构：
[1] Natl Univ Singapore Hosp, Coll Med, Singapore 117548, Singapore
[2] Yonsei Univ, Seoul, South Korea
[3] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
[4] Bundang CHA Hosp, Kyonggi Do, South Korea
[5] Pusan Natl Univ Hosp, Pusan, South Korea
[6] Natl Taiwan Univ Hosp, Taipei, Taiwan
[7] Tri Serv Gen Hosp, Taipei, Taiwan
[8] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
[9] Kaohsiung Chang Gung Mem Hosp, Med Ctr Anam, Kaohsiung Hsien, Taiwan
[10] Korea Univ, Med Ctr Kuro, Seoul, South Korea
[11] Korea Univ, Seoul, South Korea
[12] Cathay Gen Hosp, Taipei, Taiwan
[13] Changi Gen Hosp, Singapore, Singapore
[14] China Med Univ Hosp, Taichung, Taiwan
[15] Tzu Chi Gen Hosp, Hualien, Taiwan
[16] Taichung Vet Gen Hosp, Taichung, Taiwan
[17] Taipei Vet Gen Hosp, Taipei, Taiwan
[18] Res & Educ Inc, San Diego, CA USA
[19] Chung Shan Med Univ Hosp, Taichung, Taiwan
[20] Univ Calif Irvine, Orange, CA 92668 USA
[21] Valeant Res & Dev, Costa Mesa, CA USA
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [41] Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
    Haitham A. Azeem
    Ashraf M. Alkabeer
    Ali Sobhy Mohammed
    Amira Ahmed Hussein
    Egyptian Liver Journal, 11
  • [42] Some aspects of current antiviral therapies in patients with chronic hepatitis B virus infection
    Mazur, Wlodzimierz
    Logiewa-Bazger, Beata
    Polok, Justyna
    Beniowski, Marek
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03): : 950 - 955
  • [43] A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-na⟨ve patients with chronic hepatitis B
    Shin, Su Rin
    Yoo, Byung Chul
    Choi, Moon Seok
    Lee, Dong Ho
    Song, Soon Mi
    Lee, Joon Hyoek
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY INTERNATIONAL, 2011, 5 (02) : 664 - 670
  • [44] Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial
    Gao, Yanhang
    Kong, Fei
    Song, Xinwen
    Shang, Jia
    Yao, Lvfeng
    Xia, Jinyu
    Peng, Yanzhong
    Liu, Weidong
    Gong, Huanyu
    Mu, Mao
    Cui, Hesong
    Han, Tao
    Chen, Wen
    Wu, Xiaolu
    Yang, Yongfeng
    Yan, Xuebing
    Jin, Zhenjing
    Wang, Peng
    Zhu, Qingjing
    Chen, Liang
    Zhao, Caiyan
    Zhang, Dengke
    Jin, Weili
    Wang, Daidi
    Wen, Xiuhong
    Liu, Chunmei
    Jia, Jidong
    Mao, Qing
    Ding, Yanhua
    Jin, Xueyuan
    Zhang, Zong
    Mao, Qianguo
    Li, Guangming
    Niu, Junqi
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (11) : 1925 - 1932
  • [45] WEEK 48 ANALYSIS OF A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF LB80380 VS. ENTECAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B
    Lai, Ching-Lung
    Ahn, Sang Hoon
    Lee, Kwan Sik
    Um, Soon Ho
    Cho, Mong
    Yoon, Seung Kew
    Lee, Jin-Woo
    Park, Neung Hwa
    Kweon, Young-Oh
    Sohn, Joo Hyun
    Lee, Jiyoon
    Kim, Jeong-Ae
    Han, Kwang-Hyub
    Yuen, Man-Fung
    HEPATOLOGY, 2011, 54 : 1442A - 1442A
  • [46] Multicenter, randomized, open-label study of the safety and efficacy of histamine dihydrochloride and interferon alpha-2b for the treatment of chronic hepatitis C: 48-week results
    Lurie, Y
    Hyle, S
    Gehlsen, K
    JOURNAL OF HEPATOLOGY, 2001, 34 : 165 - 166
  • [47] A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B
    Su Rin Shin
    Byung Chul Yoo
    Moon Seok Choi
    Dong Ho Lee
    Soon Mi Song
    Joon Hyoek Lee
    Kwang Cheol Koh
    Seung Woon Paik
    Hepatology International, 2011, 5 : 664 - 670
  • [48] Safety and antiviral activity of RBD1016, a RNAi therapeutic, in Chinese subjects with chronic hepatitis B virus (HBV) infection
    Seto, Wai-Kay
    Liang, Zicai
    Gan, Li Ming
    Fu, Jing
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1152 - S1152
  • [49] Entecavir Plus Tenofovir Combination Therapy in Patients with Multi-drug Resistant Chronic Hepatitis B: The 48-Week Results of A Multicenter, Prospective Study
    Park, Jun Yong
    Kim, Chang Wook
    Bae, Si Hyun
    Ahn, Sang Hoon
    HEPATOLOGY, 2014, 60 : 1096A - 1096A
  • [50] ANTIVIRAL THERAPY OF CHRONIC HEPATITIS-B VIRUS-INFECTION
    ROBINSON, WS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 13 - 13
12345